Pyrrolidine derivatives as inhibitors of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/12 (2006.01) A61K 31/40 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01) A61P 39/06 (2006.01) C07D 207/16 (2006.01) C07D 401/06 (2006.01)

Patent

CA 2414311

The present invention relates to compounds of formula (I), wherein R1, R2, A, X and m are as defined in the description and the claims and dimeric forms and/or pharmaceutically acceptable esters, and/or salts thereof. The compounds are useful as inhibitors or metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.

La présente invention concerne des composés de la formule (I) dans laquelle R?1¿, R?2¿, A, X et m sont tels que définis dans le mémorandum descriptif et les revendications. Elle concerne également des formes dimères et/ou des esters pharmaceutiquement acceptables et/ou des sels desdits composés. Ces composés sont utiles comme inhibiteurs de métalloprotéases, telles que les protéases de zinc, notamment les hydrolases de zinc, et sont efficaces dans le traitement de pathologies associées à une vasoconstriction de fréquence accrue.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolidine derivatives as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolidine derivatives as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives as inhibitors of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1558833

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.